Truncating mutations in NRXN2 and NRXN1 in autism spectrum disorders and schizophrenia
Julie Gauthier(Centre Hospitalier Universitaire Sainte-Justine), Guy A. Rouleau(Montreal Neurological Institute and Hospital), Daisaku Yokomaku(University of British Columbia), Laurent Mottron(Centres Intégré Universitaires de Santé et de Services Sociaux), Mathieu Lapointe(Université de Montréal), Pierre Drapeau(Université de Montréal), Ann Marie Craig(University of British Columbia), Jacques L. Michaud(Centre Hospitalier Universitaire Sainte-Justine), Nathalie Champagne(Université de Montréal), Ridha Joober(McGill University), Dan Spiegelman(Montreal Neurological Institute and Hospital), Ronald G. Lafrenière(Xenon Pharmaceuticals (Canada)), Tabrez J. Siddiqui(Children's Hospital Research Institute of Manitoba), Ferid Fathalli(Douglas Mental Health University Institute), Anne Noreau(Centre Hospitalier de l’Université de Montréal), Huashan Peng(Douglas Mental Health University Institute), Fadi F. Hamdan(Centre Hospitalier Universitaire Sainte-Justine), Salvatore Carbonetto(McGill University), Marie‐Odile Krebs(Inserm), Lynn E. DeLisi(Cambridge Health Alliance), Éric Fombonne(Oregon Health & Science University)
Cited by 284
Related Papers
Insights into Autism Spectrum Disorder Genomic Architecture and Biology from 71 Risk Loci
|Neuron|2015|1.5k
TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis
|Nature Genetics|2008|1.5k
Neurexins Induce Differentiation of GABA and Glutamate Postsynaptic Specializations via Neuroligins
|Cell|2004|1k
NMDA Receptor Subunits Have Differential Roles in Mediating Excitotoxic Neuronal Death Both<i>In Vitro</i>and<i>In Vivo</i>
|Journal of Neuroscience|2007|770
Neuronal Polarity
|Annual Review of Neuroscience|1994|673